Literature DB >> 20290353

Dacryostenosis.

H W PRICE.   

Abstract

Keywords:  LACRIMAL ORGANS/obstruction

Mesh：

Year:  1947        PMID： 20290353     DOI： 10.1016/s0022-3476(47)80165-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  14 in total

1.  Office probing for treatment of nasolacrimal duct obstruction in infants.

Authors:  Aaron M Miller; Danielle L Chandler; Michael X Repka; Darren L Hoover; Katherine A Lee; Michele Melia; Paul J Rychwalski; David I Silbert; Roy W Beck; Eric R Crouch; Sean Donahue; Jonathan M Holmes; Graham E Quinn; Nick A Sala; Susan Schloff; David K Wallace; Nicole C Foster; Kevin D Frick; Richard P Golden; Scott R Lambert; D Robbins Tien; David R Weakley
Journal:  J AAPOS       Date:  2014-02       Impact factor: 1.220

2.  Resolution of congenital nasolacrimal duct obstruction with nonsurgical management.

Authors: 
Journal:  Arch Ophthalmol       Date:  2012-06

3.  Anatomy of the naso-lacrimal duct in new-borns: therapeutic considerations.

Authors:  K M Müller; H Busse; F Osmers
Journal:  Eur J Pediatr       Date:  1978-09-08       Impact factor: 3.183

4.  A comparison of treatment approaches for bilateral congenital nasolacrimal duct obstruction.

Authors:  Katherine A Lee; Danielle L Chandler; Michael X Repka; Michele Melia; Roy W Beck; C Gail Summers; Kevin D Frick; Nicole C Foster; Raymond T Kraker; Scott Atkinson
Journal:  Am J Ophthalmol       Date:  2013-08-15       Impact factor: 5.258

5.  Cost-effectiveness of 2 approaches to managing nasolacrimal duct obstruction in infants: the importance of the spontaneous resolution rate.

Authors:  Kevin D Frick; Luxme Hariharan; Michael X Repka; Danielle Chandler; B Michele Melia; Roy W Beck
Journal:  Arch Ophthalmol       Date:  2011-05

6.  Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years.

Authors:  Michael X Repka; Danielle L Chandler; Roy W Beck; Eric R Crouch; Sean Donahue; Jonathan M Holmes; Katherine Lee; Michele Melia; Graham E Quinn; Nick A Sala; Susan Schloff; David I Silbert; David K Wallace
Journal:  Ophthalmology       Date:  2007-11-08       Impact factor: 12.079

7.  A randomized trial comparing the cost-effectiveness of 2 approaches for treating unilateral nasolacrimal duct obstruction.

Authors: 
Journal:  Arch Ophthalmol       Date:  2012-12

8.  The rate of symptomatic improvement of congenital nasolacrimal duct obstruction in Japanese infants treated with conservative management during the 1st year of age.

Authors:  Hirohiko Kakizaki; Yasuhiro Takahashi; Shinsuke Kinoshita; Kunihiko Shiraki; Masayoshi Iwaki
Journal:  Clin Ophthalmol       Date:  2008-06

9.  Primary treatment of nasolacrimal duct obstruction with balloon catheter dilation in children younger than 4 years of age.

Authors:  Michael X Repka; B Michele Melia; Roy W Beck; Danielle L Chandler; Deborah R Fishman; Todd A Goldblum; Jonathan M Holmes; Bernard D Perla; Graham E Quinn; David I Silbert; David K Wallace
Journal:  J AAPOS       Date:  2008-10       Impact factor: 1.220

10.  Primary treatment of nasolacrimal duct obstruction with nasolacrimal duct intubation in children younger than 4 years of age.

Authors:  Michael X Repka; B Michele Melia; Roy W Beck; C Scott Atkinson; Danielle L Chandler; Jonathan M Holmes; Alexander Khammar; David Morrison; Graham E Quinn; David I Silbert; Benjamin H Ticho; David K Wallace; David R Weakley
Journal:  J AAPOS       Date:  2008-07-02       Impact factor: 1.220
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.